A team of chemist in Linköping, Sweden may have just uncovered the key to early detection of many diseases including Alzheimer’s and Parkinson’s. It could pave the way for detecting diseases before any symptoms appear.
Their work focused on the detection of amyloids. Amyloids are deformed, misshapened clumps of protein that no longer function they way they should inside the body because of their deformity. This is thought to be one of the leading causes of Alzheimer’s. Earlier detection could mean greatly improved treatments for Alzheimer’s, Parkinson’s and a host of other diseases caused by Amyloids.
These amyloids can get lodged in our tissues and clump together forming amyloidosis. In their work, the chemist probed 100s of clinical amyloidosis samples and found that it worked well and was more sensitive than the traditional method.
The authors claim that their probe can detect pre-symptomatic amyloidosis. The ability to detect amyloidosis before symptoms appears could lead to better outcomes for patients but also opens the door for new treatment and prevention options when detected early enough.
“The hope is that this can be used to diagnose patients with a risk of developing amyloidosis before they show symptoms. This would make the treatments much more effective and improve the disease prognosis.” One of the researchers told OOTBScience.
“The ability to detect amyloid plaques early is important and could allow us to develop new treatment or even cures that target the early stages of the disease”.